Brief: Avita Medical Announces FDA Approval Of Recell For Skin Repigmentation In Vitiligo Patients

AVITA Medical

16/06/2023 20:11

June 16 (Reuters) - AVITA Medical Inc  RCEL.O :
    * AVITA MEDICAL ANNOUNCES FDA APPROVAL OF RECELL FOR SKIN
REPIGMENTATION IN VITILIGO PATIENTS
    * AVITA MEDICAL INC - U.S. FDA HAS APPROVED ITS APPLICATION
FOR
PREMARKET APPROVAL OF ITS RECELL SYSTEM FOR TREATMENT OF
VITILIGO

Source text for Eikon:  ID:nGNX4hBw2h 
Further company coverage:  RCEL.O 

 ((Reuters.Briefs@thomsonreuters.com;))